Особенности врожденного иммунитета при вирусных инфекциях

03.02.2012

Литература

  1. Abe Т., Takahashi Н., Hamazaki Н. et al. Baculovirus induces an innate immune response and confers protection fram lethal Influenza virus Infection in mice // J. Immunol. 2003. V. 171. R 1133 - 1139.
  2. Akaike Т., Ando M., Oda T. et al. Dependence on 02-generation by xanthine oxidase of pathogenesis of influenza virus infection in mice // J. Clin. Invest. 1990. V. 85. P. 739 - 745.
  3. Akira S., Tokeda K. Toll-like receptor signaling // Nat. Rev Immunol. 2004. V. 4. R 499 - 511
  4. Avrll Т., De Tayrac M., Leberre C. et al. Not all polyrlboinoslnic - polyrlbocytidyllc acids (poly l:C) are equivalent for Inducing maturation of dendritic cells: Implication for a -type-1 polarized DCs // J. Immunotherapy. 2009. V. 32. R 353 - 362.
  5. Bates J., Honko Д., Graff A. et al. Mucosal adjuvant activity of flagellln In aged mice // Mech. Ageing Dev 2008. V. 129. R 271 - 281.
  6. Baudner В., Ronconi V., Casini D. et al. MF59 emulsion is an effective delivery system for a synthetic TLR 4 agonist (E6020) // Pharm. Res. 2009. V. 26. R 1477 - 1485.
  7. Bovier R, Farinelll Т., Loutan L. Interchangeablllty and tolerablllty of a virosomal and an aluminum-adsorbed hepatitis A vaccine // Vaccine. 2005. V. 23. R 2424 - 2429.
  8. Cluff C, Baldrldge J., Stover A. et al. Synthetic toll-like receptor 4 agonists stimulate innate resistance to Infectious challenge // Infect Immunity. 2005. V. 73. R 3044 - 3052.
  9. Condle R., Zak S., Good R. Effect of meningococcal endotoxin on the Immune response // Prac. Soc. ExR Biol. Med. 1955. V. 90. R 355 - 360.
  10. De Jong M., Simmons C, Thanh T. et al. Fatal outcome of human Influenza A (H5N1) Is associated with high viral load and hypercytokinemia // Nature Medicine. 2006. V. 12. R1203 - 1207.
  11. Didieriaurent A., Goulding J., Patel S. et al. Sustained desensitization to bacterial Toll-like receptor llgands after resolution of respiratory Influenza Infection // JEM. 2008. V. 205. R 323 - 329.
  12. DIebold S., Kalsho Т., Hemml H. et al. Innate antiviral responses by means of TLR7-me-dlated recognition of single-stranded RNA // Science. 2004. V. 303. R1529 -1531.
  13. Doring G., Melsner C, Stern M. A double-blind randomized placebo-controlled phase III study of Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients // Proc. Natl. Acad. Sci. USA. 2007. V. 104. R 11020 - 11025.
  14. Dupuls M., Murphy Т., HIgglns D. et al. Dendritic cells Internalize vaccine adjuvant after Intramuscular Injection // Cell Immunol. 1998. V. 186. R18 - 27.
  15. Elsenbarth S.C., Coleglo O.R., O'Connor W. et al. Crucial role for the Nalp3 Inflamma-some In the immunostimulatory properties of aluminium adjuvants // Nature. 2008. V. 453. R 1122-1126.
  16. FranchI L, Elgenbrod Т., MInoz-Planlllo R., Nunez G. The Inflammasome: a caspase-1 activation platform that regulates Immune responses and disease pathogenesis // Nat Immunol. 2009. V. 10. R 241 - 247.
  17. Fritz J., Ferrero R., Phllpott D. et al. NOD-like proteins In Immunity, inflammation and disease // Nat Immun. 2006. V. 7. R1250 - 1257.
  18. Gavin A., hloebe K., Duong B. et al. Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling // Science. 2006. V. 314. R1936 - 1938.
  19. Ghinnghelli E, Apetoh L, Tesnlere A. et al. Activation of the NLRP3 Inflammasome In dendritic cells Induces IL-ip -dependent adapflve Immunity against tumors // Nature Medicine. 2009. V. 15. R 1170 - 1178.
  20. Gorden K., Gorski K., Gibson S. et al. Synthetic TLR agonists reveal functional differences between human TLR 7 and TLR 8 // J. Immunol. 2005. V. 174. R1259 - 1268.
  21. Heer A., Shamshlev A., Donda A. et al. TLR signaling flne-tunes anti-influenza В cell responses // J. Immunol. 2007. V. 178. R 2182 - 2191.
  22. Hornung v., Rothenfusser S., Britsch S. et al. Quantitative expression of Toll-like receptor 1-10 mRNA In cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides // J. of Immunol. 2002. V. 168. R 4531 - 4537.
  23. HIgglns S., Jarnlckl A., Lavelle E. et al. TLR4 mediates vaccine-Induced protective cellular Immunity to Bordetella pertussis: role of IL-17-produclng T cells // J. Immunol. 2006. V. 177. R 7980 - 7989.
  24. Hell F, Hemml H., Hochrein H. et al. Species-specific recognition of single-stranded RNA via Toll-like receptors 7 and 8 // Science. 2004. V. 303. R 1526 - 1529.
  25. Heltzer M.L, Coffin S.E., Maurer K. et al. Immune dysregulatlon in severe Influenza // J. Leukocyte Biology. 2009. V. 85. R 1036 - 1043.
  26. Hemml H., Kalsho Т., TakeuchI 0. et al. Small anti-viral compounds activate Immune cells via theTLR7 MyD88-dependent signaling pathway// Nat Immunol. 2002 V. 3. R196 - 200.
  27. Honko A., MIzel S. Mucosal administration of flagellln Induces Innate Immunity In the mouse lung // Infect. Immun. 2004. V. 72. R 6676 - 6679.
  28. Ishlnohe Т., Tamura S., KawaguchI A. et al. Cross-protection against H5N1 Influenza virus Infection Is afforded by Intranasal Inoculation with seasonal trivalent Inactivated Influenza vaccine // J. Infect, dis. 2007. V. 196. R1313 - 1320.
  29. Janeway C.A. Jr. Approaching the asymptote? Evolufion and revolution In Immunology // Cold Spring Harb. Symp. Quant Biol. 1989. V. 54 (Pt 1). R 1 - 13.
  30. Joffre 0., Nolte M., Sporri R., Sousa C. Inflammatory signals in dendritic cell activation and the Induction of adaptive immunity// Immun. Rev 2009. V. 227. R 234 - 247.
  31. KannegantI T.D., Body-Malapel M., Amer A. et al. Critical role for Cryopyrln/Nalp3 In activation of caspase-1 In response to viral Infection and double-stranded RNA//J. Biol. Chem. 2006. V. 281. R 36560 - 36568.
  32. Kato H., Sato S., Yoneyama Y. et al. Cell type-speclflc Involvement of RIG-1 In antiviral response // Immunity. 2005. V. 6. R 981 - 988.
  33. Kaufmann S. Tuberculosis and AIDS - a devilish liaison // Drug. DIscov Tuday. 2007. V. 12. R 891 - 893.
  34. Kawal Т., Takahashi K., Sato S. et al. IPS-1 an adaptor triggering RIG-1 and Mda 5-medl-ated type I interferon Induction // Nat Immunol. 2005. V. 6. R 981 - 988.
  35. Koyama S., Ishll K., Kumar H. et al. Differential role of TLR- and RLR-sIgnalIng In the immune responses to influenza A virus infection and vaccination //J. Immunol. 2007. V. 179. R 4711 - 4720.
  36. Kumar H., Koyama S., Ishll KJ. et al. Cutting edge: cooperation of IPS-1 and TRIF-dependent pathways In poly IC-enhanced antibody production and cytotoxic T cell responses // J. Immunol. 2008. V. 180. R 683 - 687.
  37. Kato H., TakeuchI 0., Sato S. et al. Differential roles of MDA5 and RIG-1 hellcases In the recognition of RNA viruses // Nature. 2006. V. 441. R 101 - 105.
  38. Kllnman D., Xle H., Little S. et al. CpG oligonucleotides Improve the protective Immune response Induced by the anthrax vaccination of rhesus macaques // Vaccine. 2004. V 22. R 2881 - 2886.
  39. Kobyama K., Takeshlta F, Ishll K. et al. A signaling polypeptide derived from an Innate Immune adaptor molecule can be harnessed as a new class of vaccine adjuvant // J. Immunol. 2009. V. 182. R 1593 - 1601.
  40. Lau Y., Tang L, McCall A. et al. An adjuvant for the Induction of potent, protective humoral responses to an H5N1 Influenza virus vaccine with antigen-sparing effect In mice // J. Virol. 2010. V 84. R 8639 - 8649.
  41. Lau Y., Tang L, Ool E. A TLR3 llgand that exhibits potent Inhibits of Influenza virus replication and has strong adjuvant activity has the potential for dual application In an influenza pandemic // Vaccine. 2009. V 27. R 1354 - 1364.
  42. Lemaltre В., Nicolas E., MIchaut L et al. The dorsoventral regulatory gene cassette spatzle / Toll / cactus controls the potent antifungal response In Drosophila adults // Cell. 1996. V 86. R 973 - 983.